February 27, 2023 01:25 PM ESTUpdated 03:44 PM
R&D
Law

State at­tor­neys gen­er­al sue FDA over abor­tion pill ac­cess re­stric­tions

Katherine Lewin

News Reporter

A dozen De­mo­c­rat at­tor­neys gen­er­al are su­ing the FDA in fed­er­al court in the East­ern Dis­trict of Wash­ing­ton to re­move all …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

A service from the Financial Times